Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Sponsor: Bayer
Summary
The aim of this study is to assess whether increasing oral doses of Riociguat are safe and improve the well-being, symptoms and outcome in patients with pulmonary hypertension associated with left ventricular systolic dysfunction
Official title: Randomized, Double Blind, Placebo Controlled, Parallel Group, Multi-center Study to Evaluate the Hemodynamic Effects of Riociguat (BAY 63-2521) as Well as Safety and Kinetics in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
202
Start Date
2010-04-14
Completion Date
2025-07-23
Last Updated
2026-08-20
Healthy Volunteers
No
Interventions
Riociguat (Adempas, BAY63-2521)
up to 2 mg three times a day (increasing from 0.5 to 1 to 2 mg)
Riociguat (Adempas, BAY63-2521)
up to 1 mg three times a day (increasing from 0.5 to 1 mg)
Riociguat (Adempas, BAY63-2521)
fixed 0.5 mg three times a day
Placebo
Placebo three times a day
Locations (83)
Los Angeles, California, United States
San Diego, California, United States
Torrance, California, United States
Westminster, California, United States
Miami, Florida, United States
Iowa City, Iowa, United States
Baltimore, Maryland, United States
Boston, Massachusetts, United States
Rochester, Minnesota, United States
St Louis, Missouri, United States
Cincinnati, Ohio, United States
Fairfield, Ohio, United States
Falls Church, Virginia, United States
Milwaukee, Wisconsin, United States
Sydney, New South Wales, Australia
Herston, Queensland, Australia
Melbourne, Victoria, Australia
Vienna, State of Vienna, Austria
Innsbruck, Tyrol, Austria
Aalst, Belgium
Brussels, Belgium
Ghent, Belgium
Leuven, Belgium
Edmonton, Alberta, Canada
Vancouver, British Columbia, Canada
Montreal, Quebec, Canada
Québec, Quebec, Canada
Beijing, China
Shanghai, China
Shanghai, China
Brno, Czechia
Olomouc, Czechia
Prague, Czechia
Prague, Czechia
Aarhus N, Denmark
Bron, France
Lille, France
Nantes, France
Pessac, France
Rouen, France
Toulouse, France
Heidelberg, Baden-Wurttemberg, Germany
Augsburg, Bavaria, Germany
Greifswald, Mecklenburg-Vorpommern, Germany
Cologne, North Rhine-Westphalia, Germany
Erfurt, Thuringia, Germany
Naples, Campania, Italy
Pavia, Lombardy, Italy
Nagoya, Aichi-ken, Japan
Seto, Aichi-ken, Japan
Ōgaki, Gifu, Japan
Higashiibaraki, Ibaraki, Japan
Tsu, Mie-ken, Japan
Sendai, Miyagi, Japan
Kita-ku, Osaka, Osaka, Japan
Osaka, Osaka, Japan
Suita, Osaka, Japan
Kusatsu, Shiga, Japan
Sunto, Shizuoka, Japan
Arakawa-ku, Tokyo, Japan
Shinjuku-ku, Tokyo, Japan
Tanabe, Wakayama, Japan
Amsterdam, Netherlands
Amsterdam, Netherlands
Nijmegen, Netherlands
Bydgoszcz, Poland
Gdansk, Poland
Warsaw, Poland
Singapore, Singapore
Singapore, Singapore
Singapore, Singapore
A Coruña, A Coruña, Spain
Barcelona, Barcelona, Spain
Madrid, Madrid, Spain
Majadahonda, Madrid, Spain
Murcia, Murcia, Spain
Palma, Palma de Mallorca, Spain
Valencia, Valencia, Spain
Geneva, Canton of Geneva, Switzerland
Zurich, Canton of Zurich, Switzerland
Lugano, Canton Ticino, Switzerland
Cambridge, Cambridgeshire, United Kingdom
London, London, United Kingdom